bromodeoxyuridine has been researched along with g(m1) ganglioside in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, B; Johnson, TC; Kinders, R; McGee, JE | 1 |
| Moreira, LF; Naomoto, Y; Orita, K; Tanaka, N; Watanabe, R | 1 |
| Cui, X; Huang, Y; Li, J; Li, X; Zhang, Q; Zuo, P | 1 |
3 other study(ies) available for bromodeoxyuridine and g(m1) ganglioside
| Article | Year |
|---|---|
Selective protection of nonmalignant cells by a novel cell surface glycopeptide.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Cell Membrane; Cell Survival; Cerebral Cortex; Fibrosarcoma; G(M1) Ganglioside; Gangliosides; Glycopeptides; Mice | 1983 |
Cell cycle assessment of adoptive transferred lymphokine activated killer cells.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Cycle; Complement System Proteins; Cytotoxicity, Immunologic; Flow Cytometry; Fluorescent Antibody Technique; G(M1) Ganglioside; Immunotherapy, Adoptive; Interleukin-2; Isoantibodies; Killer Cells, Lymphokine-Activated; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Specific Pathogen-Free Organisms; Time Factors; Tumor Cells, Cultured | 1994 |
GM1 ganglioside prevented the decline of hippocampal neurogenesis associated with D-galactose.
Topics: Analysis of Variance; Animals; Bromodeoxyuridine; Cell Count; Cell Death; Cell Proliferation; Disease Models, Animal; Doublecortin Domain Proteins; G(M1) Ganglioside; Galactose; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Nerve Degeneration; Neuropeptides; Neuroprotective Agents; Phosphopyruvate Hydratase; Random Allocation; Regeneration | 2005 |